It was also found that TNM staging, histological grade, blood vessel invasion, SLN metastasis, and expression levels of HER-2, ER, and PR would all affect DFS and OS of patients with breast cancer (all P<0.05). This evidence concerns the gene ERBB2 and breast carcinoma.